|This Slide: #8 of 100|
Slide #8. H. Lundbeck A/S (Lundbeck) — Chelsea Therapeutics International, Ltd.
H. Lundbeck A/S (Lundbeck)
Chelsea Therapeutics International, Ltd. (CHTP)
Chelsea Therapeutics International, Ltd. (Chelsea) (Nasdaq:CHTP), a biopharmaceutical development company, has entered into a definitive agreement to be acquired by H. Lundbeck A/S (Lundbeck) (LUN.CO) (LUN DC) (HLUYY), a global pharmaceutical company that specializes in brain diseases. The details of this transaction can be found in the joint press release issued by the two companies.
Hold (2.00 out of 4)
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite